{"id":135072,"date":"2022-02-01T19:23:03","date_gmt":"2022-02-02T03:23:03","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/02\/ivermectin-shows-antiviral-effect-against-covid-japanese-company-says"},"modified":"2022-02-01T19:23:03","modified_gmt":"2022-02-02T03:23:03","slug":"ivermectin-shows-antiviral-effect-against-covid-japanese-company-says","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/02\/ivermectin-shows-antiviral-effect-against-covid-japanese-company-says","title":{"rendered":"Ivermectin shows \u2018antiviral effect\u2019 against COVID, Japanese company says"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/ivermectin-shows-antiviral-effect-against-covid-japanese-company-says2.jpg\"><\/a><\/p>\n<p>Info from Japan.<\/p>\n<hr>\n<p>TOKYO, Jan 31 (Reuters) \u2014 Japanese trading and pharmaceuticals company Kowa Co Ltd <a href=\"https:\/\/www.reuters.com\/companies\/7807.T\" target=\"_blank\" class=\"\">(7807.T)<\/a> on Monday said that anti-parasite drug ivermectin showed an \u201cantiviral effect\u201d against Omicron and other coronavirus variants in joint non-clinical research.<\/p>\n<p>The company, which <a href=\"https:\/\/rctportal.niph.go.jp\/en\/detail?trial_id=jRCT2031200120\" target=\"_blank\" class=\"\">has been working with Tokyo\u2019s Kitasato University<\/a> on testing the drug as a potential treatment for COVID-19, did not provide further details. The original Reuters story misstated that ivermectin was \u201ceffective\u201d against Omicron in Phase III clinical trials, which are conducted in humans.<\/p>\n<p>Clinical trials are ongoing, but promotion of ivermectin as a COVID-19 treatment has <a href=\"https:\/\/www.reuters.com\/lifestyle\/joni-mitchell-removes-music-spotify-over-vaccine-misinformation-2022-01-29\" target=\"_blank\" class=\"\">generated controversy<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Info from Japan. TOKYO, Jan 31 (Reuters) \u2014 Japanese trading and pharmaceuticals company Kowa Co Ltd (7807.T) on Monday said that anti-parasite drug ivermectin showed an \u201cantiviral effect\u201d against Omicron and other coronavirus variants in joint non-clinical research. The company, which has been working with Tokyo\u2019s Kitasato University on testing the drug as a potential [\u2026]<\/p>\n","protected":false},"author":609,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-135072","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/135072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/609"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=135072"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/135072\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=135072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=135072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=135072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}